Kenvue Inc. Common Stock (NY:KVUE)

17.20 -0.02 (-0.12%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Here's What to Expect From Kenvue's Next Earnings Report

April 22, 2026

Kenvue will release its first-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

Via Barchart.com

Topics ETFs

The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗

April 19, 2026

Growth stocks may be on fire again, but if you needed dividend stocks then, you still need them now. Here's a look at three of the best bets at this time.

Via The Motley Fool

Meet the Dividend King That Just Raised Its Payout For the 70th Consecutive Year. Here's Why It's a No-Brainer Buy Before the End of April. ↗

April 18, 2026

Decades of dividend increases and a 3% yield make Procter & Gamble a passive-income powerhouse.

Via The Motley Fool

Topics Economy

3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗

April 16, 2026

Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns.

Via The Motley Fool

Topics Economy

Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now ↗

April 16, 2026

Three Dividend Aristocrats offer yields above the 10-year Treasury while delivering income growth and potential capital appreciation

Via MarketBeat

Topics Bonds Earnings Economy

J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher

April 15, 2026

Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared...

Via MarketMinute

Topics Economy Intellectual Property

This Value Stock Yields 5.3% and Has Paid a Dividend for 92 Consecutive Years. Here's Why It's a Buy in April. ↗

April 15, 2026

Kimberly Clark is a worthy foundational holding in a passive-income portfolio.

Via The Motley Fool

MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat

April 14, 2026

In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of...

Via MarketMinute

Topics Bankruptcy Earnings Economy

Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone

April 14, 2026

NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across...

Via MarketMinute

Topics Economy Intellectual Property

The New J&J: A 2026 Deep Dive into the Global Healthcare Titan

April 14, 2026

As of April 14, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different entity than it was only three years ago. Following the successful spin-off of its consumer health division, Kenvue,...

Via Finterra

Topics Artificial Intelligence Death Economy

Better Buy Right Now: Johnson & Johnson Vs. Pfizer ↗

April 12, 2026

The choice is based on more than just the dividend payout.

Via The Motley Fool

Topics Artificial Intelligence

4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down ↗

April 11, 2026

These defensive consumer stocks are flashing buy signals while the market chases AI hype.

Via The Motley Fool

Topics Artificial Intelligence

Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks

April 10, 2026

As the sun sets on the era of easy profits from elevated interest rates, the titans of Wall Street are preparing to unveil a new chapter in their growth stories. For the first time in three years, the...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Could Buying This Dividend Pharma Stock Today Set You Up for Life? ↗

April 09, 2026

This Dividend King drug maker's dividend yield is roughly twice that of the S&P 500 index.

Via The Motley Fool

Topics Stocks

The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge

April 09, 2026

The global financial landscape underwent a seismic shift in the first quarter of 2026, as a "perfect storm" of stabilizing interest rates and technological urgency triggered a historic wave of mergers...

Via MarketMinute

Topics Artificial Intelligence Economy

Looks Like M&A Week in 3 Different Sectors ↗

April 08, 2026

Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals in the healthcare industry.

Via The Motley Fool

These 3 Beaten-Down Stocks Haven't Been This Cheap in Over a Decade ↗

April 08, 2026

Buying stocks at incredibly low valuations often comes with risk, but it may also result in massive returns.

Via The Motley Fool

Topics Economy World Trade

Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance

April 02, 2026

The first quarter of 2026 has officially marked the end of the deal-making drought, ushering in a lucrative "advisory windfall" for Wall Street’s elite investment banks. Driven by a surge in...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

This Healthcare Stock Barely Flinches During Market Sell-Offs ↗

April 02, 2026

Shares of Johnson & Johnson have fallen by less than 2% over the past month, while the S&P 500 has fallen by more than 7%.

Via The Motley Fool

Topics Economy Stocks

The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future

April 01, 2026

As we enter the second quarter of 2026, Johnson & Johnson (NYSE: JNJ) stands as a starkly different entity than the consumer-facing conglomerate that defined the 20th century. Having successfully shed...

Via Finterra

Topics Artificial Intelligence Earnings Economy

The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery

March 24, 2026

As the first quarter of 2026 draws to a close, the global mergers and acquisitions (M&A) market has delivered a paradox that is reshaping the financial landscape. Preliminary data reveals that total...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Breathing Easy: Prestige Consumer Healthcare Inks $1.045 Billion Deal to Acquire Breathe Right and Expansion Portfolio

March 23, 2026

In a move that signals a bold return to aggressive brand acquisition, Prestige Consumer Healthcare Inc. (NYSE: PBH) announced on March 20, 2026, that it has entered into a definitive agreement to...

Via MarketMinute

Topics Economy

2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow ↗

March 19, 2026

This stock is one to own during any market environment.

Via The Motley Fool

Topics Artificial Intelligence

2 Dividend Stocks to Double Up on Right Now ↗

March 16, 2026

Capitalize on near-term bearishness with these two high-quality dividend stocks.

Via The Motley Fool

Topics Artificial Intelligence Economy

The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape

March 16, 2026

In a move that signals a seismic shift in the global consumer goods sector, Kimberly-Clark (NYSE:KMB) is charging forward with its landmark $48.7 billion enterprise value acquisition of consumer health...

Via MarketMinute

Topics Artificial Intelligence Lawsuit

How Is Kenvue’s Stock Performance Compared to Other Consumer Staple Stocks?

March 11, 2026

While recent performance trails the industry, Kenvue continues to retain measured analyst confidence and long-term relevance.

Via Barchart.com

Topics ETFs

My Top 3 Dividend Kings to Buy for March 2026 ↗

March 10, 2026

These Dividend Kings offer price appreciation potential alongside dividend growth.

Via The Motley Fool

These 7 Elite Dividend Stocks Pay $114 Billion Annually, Combined, to Their Shareholders ↗

March 08, 2026

Seven of Wall Street's most influential businesses are doling out between $11.9 billion and $27.1 billion to their investors each year.

Via The Motley Fool

Topics Artificial Intelligence

Curious about the most active S&P500 stocks in today's session? ↗

March 05, 2026

Via Chartmill

Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate ↗

March 04, 2026

Starboard Value initiated a sizable position in Fluor, an engineering and construction firm tied to large industrial and energy projects. As investment in infrastructure, manufacturing, and energy...

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.